选择性激光小梁成形术：概述
Selective Laser Trabeculoplasty: An Overview.
作者信息
Jha Bhaskar, Bhartiya Shibal, Sharma Reetika, Arora Tarun, Dada Tanuj
机构信息
Dr RP Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Consultant, Glaucoma Services, Eye 7 Group of Hospitals, New Delhi India.
出版信息
J Curr Glaucoma Pract. 2012 May-Aug;6(2):79-90. doi: 10.5005/jp-journals-10008-1111. Epub 2012 Aug 16.
UNLABELLED
Given the obvious quality of life concerns with medical and surgical lowering of intraocular pressure (IOP), lasers have received considerable attention as a therapeutic modality for glaucoma. Selective laser trabeculoplasty (SLT) is increasingly being used in clinical practice as both the primary procedure and as an adjunct to medical and surgical therapy. Preliminary published evidence suggests that SLT is an effective, compliance-free, repeatable and safe therapeutic modality having only minor, transient, self-limiting or easily controlled side effects with no sequelae. This review attempts a broad overview of the current knowledge of its mechanism, efficacy, indications and limitations, point out the knowledge lacunae that still exist with respect to this highly promising technology which has captured the attention of glaucoma surgeons all over the world.
HOW TO CITE THIS ARTICLE
Jha B, Bhartiya S, Sharma R, Arora T, Dada T. Selective Laser Trabeculoplasty: An Overview. J Current Glau Prac 2012;6(2):79-90.
未标注
鉴于通过药物和手术降低眼压（IOP）对生活质量有着明显影响，激光作为青光眼的一种治疗方式受到了广泛关注。选择性激光小梁成形术（SLT）在临床实践中越来越多地被用作主要治疗方法以及药物和手术治疗的辅助手段。已发表的初步证据表明，SLT是一种有效、无需患者依从、可重复且安全的治疗方式，仅具有轻微、短暂、自限性或易于控制的副作用，且无后遗症。本综述试图对其机制、疗效、适应症和局限性的现有知识进行全面概述，指出关于这项备受全球青光眼外科医生关注的极具前景技术仍存在的知识空白。
如何引用本文
Jha B, Bhartiya S, Sharma R, Arora T, Dada T. 选择性激光小梁成形术：综述。《J Current Glau Prac》2012；6(2):79 - 90。
Zotero 插件